Metraipolis › archive › dc_b8ee6eb61014
SGLT-2 inhibitors improve cardiac function in hypertrophic cardiomyopathy: a real-world propensity score-matched study — Europe PMC PMID:41768590
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41768590
- DOI
- 10.3389/fcvm.2026.1742682
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T21:16:09.749Z
- SHA-256 of the archived text
9f0cb0cd3554b174e234c61f6cd07d31ca2ceceb3fe0fb8192ffc5882b17b634- Stable URL of this page
https://metraipolis.com/documento/dc_b8ee6eb61014
How to cite
SGLT-2 inhibitors improve cardiac function in hypertrophic cardiomyopathy: a real-world propensity score-matched study — Europe PMC PMID:41768590 — Europe PMC (en), https://europepmc.org/article/MED/41768590 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b8ee6eb61014 (Metraipolis archive dc_b8ee6eb61014, sha256 9f0cb0cd3554b174e234c61f6cd07d31ca2ceceb3fe0fb8192ffc5882b17b634)
BibTeX
@misc{dcb8ee6eb61014,
title = {SGLT-2 inhibitors improve cardiac function in hypertrophic cardiomyopathy: a real-world propensity score-matched study — Europe PMC PMID:41768590},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41768590},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b8ee6eb61014; sha256 9f0cb0cd3554b174e234c61f6cd07d31ca2ceceb3fe0fb8192ffc5882b17b634},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41768590. Agents can read the archived copy with the MCP tool read_document.